Fed-Fasted, Single and Multiple Ascending Dose Trial of XEN-D0103

NCT02390258 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: 10mg XEN-D0103
DRUG: Placebo
DRUG: 30mg XEN-D0103
DRUG: 60mg XEN-D0103
DRUG: 120mg XEN-D0103
DRUG: 200mg XEN-D0103
DRUG: 150mg XEN-D0103

Sponsor

Xention Ltd